Multiple Myeloma and EasyM Resource Centre.
Featured
Publications, Posters & Case Studies
wtang@rapidnovor.com2025-02-19T14:49:14-05:00
Clonotypic Mass Spectrometry with EasyM Assay for Detection of Measurable Residual Disease in Multiple Myeloma
wtang@rapidnovor.com2025-02-19T14:49:14-05:00December 17th, 2022|Poster|
wtang@rapidnovor.com2025-02-18T16:57:57-05:00
A Personalized Mass Spectrometry–Based Assay to Monitor M-Protein in Patients with Multiple Myeloma (EasyM)
wtang@rapidnovor.com2025-02-18T16:57:57-05:00September 15th, 2021|Publication|
wtang@rapidnovor.com2025-02-18T16:58:19-05:00
Mass Spectrometry Provides a Highly Sensitive Noninvasive Means of Sequencing and Tracking M-Protein in the Blood of Multiple Myeloma Patients
wtang@rapidnovor.com2025-02-18T16:58:19-05:00August 6th, 2021|Publication|